Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RSMDF) Return on Equity (2016 - 2025)

Historic Return on Equity for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to 0.24%.

  • Resmed's Return on Equity changed 0.0% to 0.24% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.24%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.26% for FY2025, which is 300.0% up from last year.
  • As of Q4 2025, Resmed's Return on Equity stood at 0.24%, which was down 0.0% from 0.24% recorded in Q3 2025.
  • In the past 5 years, Resmed's Return on Equity ranged from a high of 0.24% in Q2 2025 and a low of 0.16% during Q1 2021
  • Its 5-year average for Return on Equity is 0.22%, with a median of 0.22% in 2023.
  • As far as peak fluctuations go, Resmed's Return on Equity tumbled by -900bps in 2021, and later soared by 800bps in 2022.
  • Quarter analysis of 5 years shows Resmed's Return on Equity stood at 0.17% in 2021, then skyrocketed by 33bps to 0.23% in 2022, then dropped by -10bps to 0.2% in 2023, then rose by 17bps to 0.24% in 2024, then decreased by 0bps to 0.24% in 2025.
  • Its Return on Equity was 0.24% in Q4 2025, compared to 0.24% in Q3 2025 and 0.24% in Q2 2025.